Fortress Biotech, Inc. (FBIOP)

Import this data to Google Sheets with:

=jivedata("FBIOP","financials")

Full statements spill as a table. For one cell: =jivedata("FBIOP","Revenue") or =jivedata("FBIOP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Fortress Biotech, Inc.

FBIOP • CIK 0001429260

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$84,513	$57,675	$63,262	$68,466
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-154,154	$-120,855	$-32,915	$141,194
Net Income (Loss) Attributable to Noncontrolling Interest	$-93,517	$-74,858	$-39,730	$29,376
Net Income (Loss) Attributable to Parent	$-60,637	$-45,997	$6,815	$111,818
Preferred Stock Dividends and Other Adjustments	$8,032	$9,893	$8,697	$8,452
Net Income (Loss) Available to Common Stockholders, Basic	$-68,669	$-55,890	$-1,882	$103,367
Weighted Average Number of Shares Outstanding, Basic	8,110,906	20,784,334	27,901,889	32,889,368
Revenue from Contract with Customer, Including Assessed Tax	$59,662	$55,134	$61,239	$66,851
Other Income	$19,519	$1,000	$2,023	$1,615
Cost of Goods and Services Sold	$26,660	$20,879	$20,924	$23,556
Amortization of Intangible Assets	$3,767	$3,424	$4,258	$4,224
Research and Development Expense (Excluding Acquired in Process Cost)	$101,747	$56,629	$11,901	$1,186
Research and Development Asset Acquired Other than Through Business Combination, Written-off	$4,324	$252	$252	$252
Selling, General and Administrative Expense	$94,124	$87,731	$96,400	$68,675
Asset Impairment Charges	$3,100	$3,692	$0	$0
Costs and Expenses	$226,855	$168,054	$133,483	$97,641
Operating Income (Loss)	$-142,342	$-110,379	$-70,221	$-29,175
Investment Income, Interest	$3,003	$2,683	$2,485	$3,524
Deconsolidation, Gain (Loss), Amount	—	—	$27,127	$82
Other Nonoperating Income (Expense)	$-3,403	$1,318	$17,578	$29,434
Nonoperating Income (Expense)	$-11,291	$-10,164	$36,686	$175,201
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-153,633	$-120,543	$-33,535	$146,026
Income Tax Expense (Benefit)	$521	$312	$-620	$4,832

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$6,505	$3,260	$2,519	$2,412
Operating Lease, Right-of-Use Asset	$16,990	$13,861	$12,302	$11,357
Restricted Cash and Cash Equivalents, Noncurrent	$2,438	$1,552	$1,220	$1,220
EquitySecuritiesFVNINoncurrent	—	—	$17,660	$29,451
Finite-Lived Intangible Assets, Net	$20,287	$31,863	$27,605	$25,510
Other Assets, Noncurrent	$4,284	$3,316	$401	$1,259
Assets	$167,526	$144,223	$185,548	$316,715
Notes Payable, Noncurrent	$60,856	$57,962	$52,417	$34,602
Operating Lease, Liability, Noncurrent	$18,282	$14,750	$12,672	$11,468
Other Liabilities, Noncurrent	$1,893	$1,756	$1,447	$2,541
Liabilities	$165,939	$145,867	$123,365	$110,629
Cash and Cash Equivalents, at Carrying Value	$80,927	$57,263	$79,381	$196,576
Accounts Receivable, after Allowance for Credit Loss, Current	$15,222	$10,231	$29,783	$36,246
Inventory, Net	$10,206	$14,431	$9,624	$8,156
Prepaid Expense and Other Assets, Current	$10,500	$7,110	$4,895	$4,022
Assets Held-for-sale, Not Part of Disposal Group, Current	—	—	$0	$0
Assets, Current	$117,022	$90,371	$123,841	$245,506
Accounts Payable and Accrued Liabilities, Current	$73,562	$65,501	$47,125	$49,325
Taxes Payable, Current	$843	$932	$356	$5,179
Operating Lease, Liability, Current	$2,523	$2,623	$2,127	$2,246
Other Liabilities, Current	$163	$1,504	$135	$268
Liabilities, Current	$84,908	$71,399	$49,744	$62,018
Preferred Stock, Value, Issued	$3	$3	$3	$3
Common Stock, Value, Issued	$15	$28	$31	$33
Additional Paid in Capital	$717,396	$763,573	$783,891	$788,251
Retained Earnings (Accumulated Deficit)	$-694,870	$-740,867	$-734,052	$-624,147
Stockholders' Equity Attributable to Parent	$22,544	$22,737	$49,873	$164,140
Stockholders' Equity Attributable to Noncontrolling Interest	$-20,957	$-24,381	$12,310	$41,946
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$1,587	$-1,644	$62,183	$206,086
Preferred Stock, Shares Authorized	15,000,000	15,000,000	15,000,000	15,000,000
Preferred Stock, Shares Issued	3,427,138	3,427,138	3,427,138	3,427,138
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	15,093,053	27,908,839	31,364,094	33,311,012

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-154,154	$-120,855	$-32,915	$141,194
Net Cash Provided by (Used in) Operating Activities	$-128,225	$-80,191	$-65,777	$125,920
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-97,589	$-24,550	$21,786	$122,190
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$83,365	$58,815	$80,601	$245,103
Depreciation	$2,230	$1,040	$403	$372
Payments to Acquire Intangible Assets	$5,000	$15,000	$0	$0
Gain (Loss) on Disposition of Property Plant Equipment	$1,466	$-29	$0	$0
Proceeds from Sale of Other Property, Plant, and Equipment	$6,000	$0	$1,165	$0
Accounts Receivable, Credit Loss Expense (Reversal)	$435	$516	$-211	$54
Proceeds from Divestiture of Businesses, Net of Cash Divested	—	—	$8,956	$8,956
Amortization of Debt Discount (Premium)	$3,032	$2,054	$1,404	$2,336
Net Cash Provided by (Used in) Investing Activities	$-2,103	$-15,000	$10,121	$2,791
Gain (Loss) on Termination of Lease	—	—	$394	$0
Gain (Loss) on Extinguishment of Debt	$-2,796	$-2,457	$0	$0
Amortization of Intangible Assets	$3,767	$3,424	$4,258	$4,224
Operating Lease, Right-of-Use Asset, Amortization Expense	$2,078	$2,846	$1,943	$1,917
Share-based Payment Arrangement, Noncash Expense	$17,029	$32,619	$28,739	$10,291
Equity Securities, FV-NI, Unrealized Gain (Loss)	—	—	$15,075	$15,075
Deconsolidation, Gain (Loss), Amount	—	—	$27,127	$82
Impairment of Long-Lived Assets Held-for-use	$3,143	$3,692	$0	$0
Increase (Decrease) in Accounts Receivable	$-12,551	$-4,475	$19,341	$20,656
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	$8,032	$4,016	$0	$0
Increase (Decrease) in Inventories	$-3,953	$4,225	$-4,807	$-4,696
Increase (Decrease) Due from Other Related Parties	$29	$4	$-13	$-52
Proceeds from Issuance of Common Stock	$2,041	$3,734	$1,008	$-1
Increase (Decrease) in Prepaid Expense and Other Assets	$848	$624	$-1,546	$-205
Increase (Decrease) in Other Operating Assets	$808	$-968	$-330	$738
Proceeds from Warrant Exercises	$382	$181	$2,647	$3,272
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-24,382	$-6,390	$-7,971	$2,159
Increase (Decrease) in Income Taxes Payable	$121	$89	$-576	$4,195
Payments of Ordinary Dividends, Common Stock	$736	$694	$664	$498
Increase (Decrease) in Other Operating Liabilities	$-786	$1,204	$-1,678	$-915
Repayments of Notes Payable	$1,000	$1,250	$625	$0
Proceeds from (Repayments of) Related Party Debt	$14,529	$9,950	$0	$0
Net Cash Provided by (Used in) Financing Activities	$32,739	$70,641	$77,442	$-6,521
Interest Paid, Excluding Capitalized Interest, Operating Activities	$7,945	$7,159	$7,386	$6,425
Income Taxes Paid, Net	$-55	$120	$49	$147
Deferred Offering Costs	—	$118	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("FBIOP","financials")

Full statements spill as a table. For one cell: =jivedata("FBIOP","Revenue") or =jivedata("FBIOP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.